CUI Global (CUI) Stock Price, News & Analysis

Company Overview

CUI Global, Inc., through its subsidiaries, engages in the acquisition, development, and commercialization of power and electromechanical components worldwide. The company operates in two segments, Power and Electromechanical, and Energy. The Power and Electromechanical segment offers power solutions that consists of external and embedded ac-dc power supplies, dc-dc converters, and intelligent control of energy products; components, including connectors, speakers, and buzzers; and control solutions comprising encoders and sensors, which addresses power and related accessories to consumer electronics, medical, and defense industries. The Energy segment provides natural gas infrastructure and advanced technologies, including metering, odorization, remote telemetry units, and a range of personalized gas engineering solutions to the gas utilities, power generation, emissions, manufacturing, and automotive industries. CUI Global, Inc. was founded in 1998 and is based in Tualatin, Oregon.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.77 to $4.44
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 79,161 shs
• Market Capitalization: $9 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CUI Stock Analysis - Frequently Asked Questions

How were CUI Global's earnings last quarter?

CUI Global Inc (NASDAQ:CUI) posted its quarterly earnings data on Monday, March, 30th. The industrial products company reported $0.16 earnings per share for the quarter, topping the consensus estimate of ($0.12) by $0.28. The industrial products company had revenue of $5.70 million for the quarter. CUI Global had a negative net margin of 1.96% and a negative trailing twelve-month return on equity of 31.05%.

What other stocks do shareholders of CUI Global own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CUI Global investors own include FuelCell Energy (FCEL), Onconova Therapeutics (ONTX), Ampio Pharmaceuticals (AMPE), Avino Silver & Gold Mines (ASM), CTI BioPharma (CTIC), Inovio Pharmaceuticals (INO) and Inseego (INSG).

Company Calendar

• Last Earnings: 3/30/2020
• Today: 6/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Industrials
• Industry: Electronic Parts & Equipment
• Sub-Industry: N/A
• Current Symbol: NASDAQ:CUI
• CIK: 1108967
• Web: www.cuiglobal.com
• Phone: 503-612-2300
• Fax: N/A
• Employees: 357
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($0.47)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$1.13 million
• Net Margins: -1.96%
• Pretax Margin: N/A
• Return on Equity: -31.05%
• Return on Assets: -17.86%

Debt

• Debt-to-Equity Ratio: 0.11
• Current Ratio: 2.61
• Quick Ratio: 2.50

Sales & Book Value

• Annual Sales: $23.49 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $1.50 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 28,421,000
• Free Float: N/A
• Market Cap: $9 thousand
• Optionable: Not Optionable
• Beta: 0.99